Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation.

Where this comes from

• Record sourced from PubMed, PMID 29020096.
• Also identified by DOI 10.1371/journal.pone.0186528 and PMC identifier 5636156.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.